TY - JOUR
T1 - Pre-transplant risk factors for cryptogenic organizing pneumonia/ bronchiolitis obliterans organizing pneumonia after hematopoietic cell transplantation
AU - Nakasone, H.
AU - Onizuka, M.
AU - Suzuki, N.
AU - Fujii, N.
AU - Taniguchi, S.
AU - Kakihana, K.
AU - Ogawa, H.
AU - Miyamura, K.
AU - Eto, T.
AU - Sakamaki, H.
AU - Yabe, H.
AU - Morishima, Y.
AU - Kato, K.
AU - Suzuki, R.
AU - Fukuda, T.
PY - 2013/10
Y1 - 2013/10
N2 - Cryptogenic organizing pneumonia (COP), previously known as bronchiolitis obliterans organizing pneumonia (BOOP), is a significant complication after allogeneic hematopoietic SCT (HCT). However, the pathogenesis of this complication has not yet been elucidated. Therefore, we identified the pre-transplant risk factors for the development of COP/BOOP using the Japan transplant registry database between 2005 and 2009. Among 9550 eligible recipients, 193 experienced COP/BOOP (2%). HLA disparity (odds ratio (OR) 1.51, P=0.05), female-to-male HCT (OR 1.53, P=0.023), and PBSC transplant (OR 1.84, P=0.0076) were significantly associated with an increased risk of COP/BOOP. On the other hand, BU-based myeloablative conditioning (OR 0.52, P=0.033), or fludarabine-based reduced-intensity conditioning (OR 0.50, P=0.0011) in comparison with a TBI-based regimen and in vivo T-cell depletion (OR 0.46, P=0.055) were associated with a lower risk. Of the 193 patients with COP/BOOP, 77 died, including non-relapse death in 46 (59%). Pulmonary failure and fatal infection accounted for 41% (n=19) and 26% (n=12) of the non-relapse death. Allogeneic immunity and conditioning toxicity could be associated with COP/BOOP. Prospective studies are required to elucidate the true risk factors for COP/BOOP and to develop a prophylactic approach.
AB - Cryptogenic organizing pneumonia (COP), previously known as bronchiolitis obliterans organizing pneumonia (BOOP), is a significant complication after allogeneic hematopoietic SCT (HCT). However, the pathogenesis of this complication has not yet been elucidated. Therefore, we identified the pre-transplant risk factors for the development of COP/BOOP using the Japan transplant registry database between 2005 and 2009. Among 9550 eligible recipients, 193 experienced COP/BOOP (2%). HLA disparity (odds ratio (OR) 1.51, P=0.05), female-to-male HCT (OR 1.53, P=0.023), and PBSC transplant (OR 1.84, P=0.0076) were significantly associated with an increased risk of COP/BOOP. On the other hand, BU-based myeloablative conditioning (OR 0.52, P=0.033), or fludarabine-based reduced-intensity conditioning (OR 0.50, P=0.0011) in comparison with a TBI-based regimen and in vivo T-cell depletion (OR 0.46, P=0.055) were associated with a lower risk. Of the 193 patients with COP/BOOP, 77 died, including non-relapse death in 46 (59%). Pulmonary failure and fatal infection accounted for 41% (n=19) and 26% (n=12) of the non-relapse death. Allogeneic immunity and conditioning toxicity could be associated with COP/BOOP. Prospective studies are required to elucidate the true risk factors for COP/BOOP and to develop a prophylactic approach.
KW - GVHD
KW - TBI
KW - bronchiolitis obliterans organizing pneumonia
KW - cryptogenic organizing pneumonia
KW - female-to-male transplantation
KW - risk factors
UR - http://www.scopus.com/inward/record.url?scp=84885672140&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84885672140&partnerID=8YFLogxK
U2 - 10.1038/bmt.2013.116
DO - 10.1038/bmt.2013.116
M3 - Article
C2 - 23933758
AN - SCOPUS:84885672140
SN - 0268-3369
VL - 48
SP - 1317
EP - 1323
JO - Bone Marrow Transplantation
JF - Bone Marrow Transplantation
IS - 10
ER -